P3 Health Partners Stock
P3 Health Partners Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Country
- United States
- CEO
- Aric Coffman
- Employees
- 320
- Market cap
- $14 M
- IPO
- 06/04/2021
- Web
- www.p3hp.org
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. The company operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.
P3 Health Partners stock: price history
1D
+0.0%
1W
-16.4%
1M
-45.6%
6M
+59.2%
YTD
+18.6%
1Y
-53.9%
2Y
-77.6%
5Y
-99.2%
10Y
–
Next earnings date
Next earnings date
12/11/2026 (in 26 days)
Volatility around earnings
~90% stronger price swings than usual
Ask the agents about P3 Health Partners
Analyst assessment of P3 Health Partners
PRICE TARGET LOW
US$14.00
CONSENSUS
US$18.50
MEDIAN
US$18.50
PRICE TARGET HIGH
US$23.00
0
STRONG BUY
2
BUY
2
HOLD
0
SELL
0
STRONG SELL
4
TOTAL · Buy
As of: 22/05/2026
P3 Health Partners stock metrics
P/E
-0.13
P/B
0.19
EV/EBITDA
-1.49
RETURN ON EQUITY
10.3%
NET MARGIN
1.9%
DEBT/EQUITY
1.8
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
55.4%
FLOAT SHARES
1,815,674
AVG. DAILY VOLUME (30D)
14,459
Insider transactions (SEC)
Hudson Vegas Investment SPV, LLC
Hudson Vegas Investment SPV, LLC
Hudson Vegas Investment SPV, LLC
Hudson Vegas Investment SPV, LLC
Hudson Vegas Investment SPV, LLC
Institutional holders
Comparable stocks
Frequently asked questions about P3 Health Partners stock
What does P3 Health Partners do?
P3 Health Partners Inc. is a company in the Healthcare sector, Medical - Care Facilities industry, headquartered in United States.
The CEO is Aric Coffman, the company employs around 320 people.
The IPO was on 06/04/2021; the stock trades on NASDAQ under the ticker PIII.
What do analysts say about P3 Health Partners stock?
4 analysts rate the stock, the consensus is Buy (as of 22/05/2026).
The average price target is US$18.50, ranging from US$14.00 to US$23.00, with a median of US$18.50.
This is an external assessment, not a statement by Market Jury.
When does P3 Health Partners report next?
The next earnings date is 12/11/2026.
Around past earnings, price swings were roughly 90% stronger than usual.
Does P3 Health Partners pay a dividend?
No, P3 Health Partners currently does not pay a dividend.
Which stocks are comparable to P3 Health Partners?
Comparable stocks include HCA Healthcare, Tenet Healthcare, DaVita, Universal Health Services, Hims & Hers Health, LifeStance Health Group, Concentra Group Holdings Parent and Acadia Healthcare Company.
How can I get P3 Health Partners stock analyzed?
Clicking "Analyze stock" lets five strategies assess P3 Health Partners against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.